5q01
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) complexed with the allosteric inhibitor 1-(5-bromo-1,3-thiazol-2-yl)-3-[4-(4,5-dichloro-2-methylpyrazol-3-yl)oxyphenyl]sulfonylurea== | |
| + | <StructureSection load='5q01' size='340' side='right' caption='[[5q01]], [[Resolution|resolution]] 2.60Å' scene=''> | ||
| + | == Structural highlights == | ||
| + | <table><tr><td colspan='2'>[[5q01]] is a 8 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5Q01 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5Q01 FirstGlance]. <br> | ||
| + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=95G:N-[(5-bromo-1,3-thiazol-2-yl)carbamoyl]-4-[(3,4-dichloro-1-methyl-1H-pyrazol-5-yl)oxy]benzene-1-sulfonamide'>95G</scene></td></tr> | ||
| + | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Fructose-bisphosphatase Fructose-bisphosphatase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.1.3.11 3.1.3.11] </span></td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5q01 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5q01 OCA], [http://pdbe.org/5q01 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5q01 RCSB], [http://www.ebi.ac.uk/pdbsum/5q01 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5q01 ProSAT]</span></td></tr> | ||
| + | </table> | ||
| - | + | ==See Also== | |
| - | + | *[[Bile acid receptor|Bile acid receptor]] | |
| - | + | __TOC__ | |
| - | [[Category: | + | </StructureSection> |
| + | [[Category: Fructose-bisphosphatase]] | ||
| + | [[Category: Alker, A]] | ||
| + | [[Category: Banner, D]] | ||
| + | [[Category: Benz, J]] | ||
| + | [[Category: Burley, S K]] | ||
| + | [[Category: Joseph, C]] | ||
| + | [[Category: Kuhn, B]] | ||
[[Category: Rudolph, M]] | [[Category: Rudolph, M]] | ||
[[Category: Ruf, A]] | [[Category: Ruf, A]] | ||
| - | [[Category: | + | [[Category: Shao, C]] |
| + | [[Category: Tetaz, T]] | ||
[[Category: Yang, H]] | [[Category: Yang, H]] | ||
| - | [[Category: | + | [[Category: D3r docking]] |
| - | [[Category: | + | [[Category: Hydrolase-hydrolase inhibitor complex]] |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
Revision as of 06:32, 9 January 2019
Human liver fructose-1,6-bisphosphatase 1 (fructose 1,6-bisphosphate 1-phosphatase, E.C.3.1.3.11) complexed with the allosteric inhibitor 1-(5-bromo-1,3-thiazol-2-yl)-3-[4-(4,5-dichloro-2-methylpyrazol-3-yl)oxyphenyl]sulfonylurea
| |||||||||||
